Morning Edition updates its GLP-1 story

NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss drugs. This one added some patients talking about stockpiling compounded semaglutide/tirzepatide, and on Lilly’s latest efforts to block compounding. And yes, it included comments from APC’s Scott Brunner.

Unfortunately the text version is an older story, but you can listen to the Morning Edition piece here:

The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs”...

Inside Health Policy used APC for information in its piece “Uncertainty Looms Over Bulk Production...

NPR’s Sydney Lupkin took another angle on the GLP-1 story: What happens when patients use an...

Morning Edition updates its GLP-1 story

Related posts

A quick quote from Scott in WaPo

We gave background to Inside Health Policy

NPR shows why license-lookup matters